Abstract
Triphala, an ayurvedic formulation, showed a substantial antiproliferative effect against various human cancer cells including breast cancer cells. In vitro, anticancer and pro‐apoptotic studies were carried out using MCF‐7 breast cancer cell line to demonstrate its anticancer activity. Cell proliferation by MTT on Human breast cancer cells (1×106/ml) Flow cytometric cell cycle analysis, ELISA based quantification of cytosolic cytochrome c, Bax and Bcl‐2 levels and colorimetric assays of caspases‐3 and ‐9 were performed using breast cancer cells to demonstrate the pro‐apoptotic activity of triphala.Triphala showed substantial anti‐proliferative activity. In pro‐apoptotic studies, sub‐G0 cell phase population elevation, an increase of cytosolic cytochrome c and Bax levels, decrease of Bcl‐2 levels and enhanced caspases‐3 and ‐9 activities were observed in triphala‐treated MCF‐7 breast cancer cells. The results concluded that anticancer and apoptosis‐inducing potential of triphala in MCF‐7 breast cancer cells. Further detailed studies are in progress.This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
